Cargando…

The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't

Detalles Bibliográficos
Autores principales: Malek, Alexandre E, Cornejo, Paulette Pinargote, Daoud, Nour, Alam, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582594/
https://www.ncbi.nlm.nih.gov/pubmed/34747190
http://dx.doi.org/10.2217/imt-2021-0235
_version_ 1784597023785222144
author Malek, Alexandre E
Cornejo, Paulette Pinargote
Daoud, Nour
Alam, Mohammad
author_facet Malek, Alexandre E
Cornejo, Paulette Pinargote
Daoud, Nour
Alam, Mohammad
author_sort Malek, Alexandre E
collection PubMed
description
format Online
Article
Text
id pubmed-8582594
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Future Medicine Ltd
record_format MEDLINE/PubMed
spelling pubmed-85825942021-11-12 The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't Malek, Alexandre E Cornejo, Paulette Pinargote Daoud, Nour Alam, Mohammad Immunotherapy Editorial Future Medicine Ltd 2021-11-08 2021-10 /pmc/articles/PMC8582594/ /pubmed/34747190 http://dx.doi.org/10.2217/imt-2021-0235 Text en © 2021 Future Medicine Ltd https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Editorial
Malek, Alexandre E
Cornejo, Paulette Pinargote
Daoud, Nour
Alam, Mohammad
The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
title The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
title_full The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
title_fullStr The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
title_full_unstemmed The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
title_short The mRNA COVID-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
title_sort mrna covid-19 vaccine in patients with cancer receiving checkpoint inhibitor therapy: what we know and what we don't
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582594/
https://www.ncbi.nlm.nih.gov/pubmed/34747190
http://dx.doi.org/10.2217/imt-2021-0235
work_keys_str_mv AT malekalexandree themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT cornejopaulettepinargote themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT daoudnour themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT alammohammad themrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT malekalexandree mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT cornejopaulettepinargote mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT daoudnour mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont
AT alammohammad mrnacovid19vaccineinpatientswithcancerreceivingcheckpointinhibitortherapywhatweknowandwhatwedont